Increased incidence of silent ischemia after acute myocardial infarction

G J Taylor1, R E Katholi, K Womack

  • 1Prairie Cardiovascular Center, Springfield, Ill.

JAMA
|September 16, 1992
PubMed

Insights

Patients receiving thrombolytic therapy for myocardial infarction experienced significantly less angina during induced ischemia compared to those with existing angina. This suggests silent ischemia is common after thrombolysis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Myocardial Infarction Research

Background:

  • Angina pectoris is a hallmark symptom of myocardial ischemia.
  • Thrombolytic therapy is a critical treatment for acute myocardial infarction (AMI).
  • The presence and severity of ischemia after AMI and thrombolysis require further investigation.

Purpose of the Study:

  • To compare the incidence of angina pectoris during induced myocardial ischemia.
  • To evaluate patients treated with thrombolytic therapy for AMI versus patients with pre-existing angina pectoris.
  • To assess ischemic responses and myocardial viability post-thrombolysis.

Main Methods:

  • A comparative study conducted at a tertiary cardiology referral center.
  • Twenty-five patients with angina pectoris and 30 patients 2 days post-thrombolytic therapy for AMI underwent percutaneous transluminal coronary angioplasty (PTCA).
  • Coronary artery occlusion was induced for 5 minutes using balloon dilatation during PTCA, with assessments via electrocardiograms and pulmonary artery wedge pressure.

Main Results:

  • Angina developed in 64% (16/25) of patients in the angina pectoris group during balloon occlusion.
  • In contrast, only 30% (9/30) of patients in the thrombolysis group reported angina during occlusion of the infarct artery (P < .01).
  • Electrocardiographic responses to ischemia and changes in pulmonary wedge pressure were comparable between the two groups.

Conclusions:

  • Patients undergoing thrombolytic therapy for myocardial infarction exhibit a lower incidence of angina during induced ischemia.
  • Silent myocardial ischemia appears to be prevalent in patients after thrombolytic treatment for AMI.
  • These findings highlight the potential for unrecognized ischemic events in the post-thrombolysis period.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiovascular System Abnormal Findings II: Auscultation01:25

Cardiovascular System Abnormal Findings II: Auscultation

Auscultation, an essential part of a heart examination, is done using a stethoscope. It provides crucial information about heart function and possible heart problems. Due to heart problems, abnormal sounds can be heard during systole or diastole. These sounds include S3 and S4 gallops, opening snaps, systolic clicks, and murmurs.
Abnormal Heart Sounds
Gallops:
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...